Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial
Circulation: Cardiovascular Quality and Outcomes · 2024-03 · 17 (3)
DOI: 10.1161/circoutcomes.123.010230 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2024-03. Verfasst von David Hong und 28 weiteren Autor:innen. Beteiligte Einrichtung: Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (D.H., K.H.C., T.K.P., J.H.Y., S.-H.C., H.-C.G., Y.B.S., J.-Y.H., J.…. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Although clinical benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) in patients with complex coronary artery lesions have been observed in previous trials, the cost-effectiveness of this strategy is uncertain. METHODS: RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance vs Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) was conducted in Korea between May 2018 and May 2021. This prespecified cost-effectiveness substudy was conducted using Markov model that simulated 3 states: (1) post-PCI, (2) spontaneous myocardial infarction, and (3) death. A simulated cohort was derived from the intention-to-treat population, and input parameters were extracted from either the trial data or previous publications. Cost-effectiveness was evaluated using time horizon of 3 years (within trial) and lifetime. The primary outcome was incremental cost-effectiveness ratio (ICER), an indicator of incremental cost on additional quality-adjusted life years (QALYs) gained, in intravascular imaging-guided PCI compared with angiography-guided PCI. The current analysis was performed using the Korean health care sector perspective with reporting the results in US dollar (1200 Korean Won, ₩=1 dollar, $). Willingness to pay threshold was $35 000 per QALY gained. RESULTS: A total of 1639 patients were included in the trial. During 3-year follow-up, medical costs ($8661 versus $7236; incremental cost, $1426) and QALY (2.34 versus 2.31; incremental QALY, 0.025) were both higher in intravascular imaging-guided PCI than angiography-guided PCI, resulting incremental cost-effectiveness ratio of $57 040 per QALY gained within trial data. Conversely, lifetime simulation showed total cumulative medical cost was reversed between the 2 groups ($40 455 versus $49 519; incremental cost, −$9063) with consistently higher QALY (8.24 versus 7.89; incremental QALY, 0.910) in intravascular imaging-guided PCI than angiography-guided PCI, resulting in a dominant incremental cost-effectiveness ratio. Consistently, 70% of probabilistic iterations showed cost-effectiveness of intravascular imaging-guided PCI in probabilistic sensitivity analysis. CONCLUSIONS: The current cost-effectiveness analysis suggests that imaging-guided PCI is more cost-effective than angiography-guided PCI by reducing medical cost and increasing quality-of-life in complex coronary artery lesions in long-term follow-up. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03381872.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (D.H., K.H.C., T.K.P., J.H.Y., S.-H.C., H.-C.G., Y.B.S., J.-Y.H., J.M.L.).
- Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (J.L., J.C., D.K.).
- Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea (J.L., J.C., D.K.).
- College of Pharmacy, Ajou University, Suwon, South Korea (H.L.).
- Department of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD (E.G.).
- Chonnam National University Hospital, Gwangju, Korea (S.H.L.).
ORCID-Profile: David Hong, Hankil Lee, Juhee Cho, Eliseo Guallar, Ki Hong Choi, Seung Hun Lee, Doosup Shin, Seung-Jae Lee, Sang Yeub Lee, Sang Min Kim, Kyeong Ho Yun, Jae Young Cho, Hyo-Suk Ahn, Chang-Wook Nam, Hyuck-Jun Yoon, Wang Soo Lee, Taek Kyu Park, Jeong Hoon Yang, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Young Bin Song, Joo-Yong Hahn, Danbee Kang, Joo Myung Lee
Zitieren
APA
Hong, D., Lee, J., Lee, H., Cho, J., Guallar, E., Choi, K. H., Lee, S. H., Shin, D., Lee, J. Y., Lee, S. J., Lee, S. Y., Kim, S. M., Yun, K. H., Cho, J. Y., Kim, C. J., Ahn, H. S., Nam, C. W., Yoon, H. J., Park, Y. H., …, & RENOVATE-COMPLEX-PCI Investigators (2024). Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial. Circulation: Cardiovascular Quality and Outcomes, 17(3). https://doi.org/10.1161/circoutcomes.123.010230
Vancouver
Hong D, Lee J, Lee H, Cho J, Guallar E, Choi KH, et al. Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial. Circulation: Cardiovascular Quality and Outcomes. 2024;17(3). doi:10.1161/circoutcomes.123.010230
BibTeX
@article{Hong2024,
author = {Hong, David and Lee, Jin and Lee, Hankil and Cho, Juhee and Guallar, Eliseo and Choi, Ki Hong and Lee, Seung Hun and Shin, Doosup and Lee, Jong-Young and Lee, Seung-Jae and Lee, Sang Yeub and Kim, Sang Min and Yun, Kyeong Ho and Cho, Jae Young and Kim, Chan Joon and Ahn, Hyo-Suk and Nam, Chang-Wook and Yoon, Hyuck-Jun and Park, Yong Hwan and Lee, Wang Soo and Park, Taek Kyu and Yang, Jeong Hoon and Choi, Seung-Hyuk and Gwon, Hyeon-Cheol and Song, Young Bin and Hahn, Joo-Yong and Kang, Danbee and Lee, Joo Myung and RENOVATE-COMPLEX-PCI Investigators, RENOVATE-COMPLEX-PCI Investigators},
title = {Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial},
journal = {Circulation: Cardiovascular Quality and Outcomes},
year = {2024},
volume = {17},
number = {3},
doi = {10.1161/circoutcomes.123.010230}
}
EUVIMED